← Back to all trials
Completed
NCT07405177
A Study of MK-7240 in Healthy Participants (MK-7240-009)
Conditions: Healthy
Sex: All
Ages: 18 Years – 55 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 330
Sponsor: Merck Sharp & Dohme LLC
Location: Nucleus Network ( Site 0002) Brisbane Queensland
Summary
The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.
Eligibility Criteria
Inclusion Criteria
The main inclusion criteria include but are not limited to the following:
* Has a body-mass index (BMI) between 18 and 32 kg/m\^2
Exclusion Criteria
The main exclusion criteria include but are not limited to the following:
* Has a history of more than 1 episode of herpes zoster infection or history of disseminated herpes zoster infection
* Has a history of or current active tuberculosis (TB) infection or history of latent TB that was not fully treated
Source: ClinicalTrials.gov (NCT07405177). StuddyBuddy aggregates publicly available trial information.
